v3.26.3
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Amorphous Materials, LLC (“AML”) [Member]
Preferred Stock [Member]
Amorphous Materials, LLC (“AML”) [Member]
Common Stock [Member]
Amorphous Materials, LLC (“AML”) [Member]
Additional Paid-in Capital [Member]
Amorphous Materials, LLC (“AML”) [Member]
AOCI Attributable to Parent [Member]
Amorphous Materials, LLC (“AML”) [Member]
Retained Earnings [Member]
Amorphous Materials, LLC (“AML”) [Member]
Visimid Technologies [Member]
Preferred Stock [Member]
Visimid Technologies [Member]
Common Stock [Member]
Visimid Technologies [Member]
Additional Paid-in Capital [Member]
Visimid Technologies [Member]
AOCI Attributable to Parent [Member]
Visimid Technologies [Member]
Retained Earnings [Member]
Visimid Technologies [Member]
Private Placement [Member]
Common Stock [Member]
Private Placement [Member]
Additional Paid-in Capital [Member]
Private Placement [Member]
AOCI Attributable to Parent [Member]
Private Placement [Member]
Retained Earnings [Member]
Private Placement [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balances (in shares) at Jun. 30, 2025                                   24,956 42,949,307        
Balances at Jun. 30, 2025                                   $ 34,232,510 $ 429,493 $ 244,953,346 $ 978,686 $ (230,716,757) $ 15,644,768
Exercise of stock options, RSUs & RSAs, net (in shares)                                   0 8,583        
Exercise of stock options, RSUs & RSAs, net                                   $ 0 $ 86 (86) 0 0 0
Issuance of common stock for acquisition (in shares)             0 112,323                              
Issuance of common stock for acquisition             $ 0 $ 1,123 $ 348,877 $ 0 $ 0 $ 350,000                      
Stock-based compensation on stock options, RSUs & RSAs                                   0 0 349,624 0 0 349,624
Foreign currency translation adjustment                                   0 0 0 92,383 0 92,383
Net loss                                   $ 0 $ 0 0 0 (2,893,002) (2,893,002)
Balances (in shares) at Sep. 30, 2025                                   24,956 44,670,213        
Balances at Sep. 30, 2025                                   $ 34,232,510 $ 446,702 253,529,806 1,071,069 (233,609,759) 21,437,818
Issuance of common stock under private equity placement (in shares)                         1,600,000                    
Issuance of common stock under private equity placement                         $ 16,000 $ 7,878,045 $ 0 $ 0 $ 7,894,045            
Balances (in shares) at Jun. 30, 2026                                   6,492 69,963,045        
Balances at Jun. 30, 2026                                   $ 8,906,686 $ 699,630 398,726,619 1,308,868 (251,262,320) 149,472,797
Employee Stock Purchase Plan (in shares)                                   0 2,713        
Employee Stock Purchase Plan                                   $ 0 $ 27 44,330 0 0 44,357
Exercise of stock options, RSUs & RSAs, net (in shares)                                   0 661        
Exercise of stock options, RSUs & RSAs, net                                   $ 0 $ 7 (7) 0 0 0
Issuance of common stock for acquisition (in shares) 0 121,259                                          
Issuance of common stock for acquisition $ 0 $ 1,213 $ 1,621,666 $ 0 $ 0 $ 1,622,879                                  
Stock-based compensation on stock options, RSUs & RSAs                                   0 0 1,753,949 0 0 1,753,949
Foreign currency translation adjustment                                   0 0 0 58,796 0 58,796
Net loss                                   $ 0 $ 0 0 0 (1,700,754) (1,700,754)
Balances (in shares) at Sep. 30, 2026                                   6,492 70,087,678        
Balances at Sep. 30, 2026                                   $ 8,906,686 $ 700,877 $ 402,146,557 $ 1,367,664 $ (252,963,074) $ 151,252,024